VIA
IMCR icon

Virtus Investment Advisers’s Immunocore IMCR Stock Holding History

Virtus Investment Advisers’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.27M Buy
40,155
+17,215
+75% +$509K 0.3% 160
2026
Q1 		$692K Buy
22,940
+4,371
+24% +$141K 0.19% 180
2025
Q4 		$645K Buy
18,569
+6,097
+49% +$215K 0.18% 206
2025
Q3 		$453K Hold
12,472
– – 0.13% 212
2025
Q2 		$391K Buy
12,472
+625
+5% +$19.4K 0.13% 228
2025
Q1 		$352K Buy
+11,847
New +$355K 0.1% 227

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Virtus Investment Advisers's IMCR Position: Q2 2026 in Review

Virtus Investment Advisers increased its Immunocore (IMCR) stake by 75% in Q2 2026, buying an estimated $509K and bringing the position to 40,155 shares worth $1.27M. The position accounts for 0.3% of the portfolio, ranked #160.

Virtus Investment Advisers first reported a position in IMCR in Q1 2025 and has held it in 6 quarters since. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Virtus Investment Advisers held 40,155 shares of Immunocore worth $1.27M as of Q2 2026.
  • Virtus Investment Advisers bought 17,215 Immunocore shares in Q2 2026, an estimated $509K.
  • Immunocore made up 0.3% of Virtus Investment Advisers's portfolio in Q2 2026, its #160 holding.
  • Virtus Investment Advisers first reported a position in Immunocore in Q1 2025 and has held it in 6 quarters since.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.